Leapfrog CEO: CMS’ readmission reduction program is imperfect, but effective

Critics of CMS’ Hospital Readmission Reduction Program are often quick to point out its flaws. However, the healthcare industry should work together to refine this program, rather than just “throw the baby out with the bath water,” Leah Binder, president and CEO of The Leapfrog Group, wrote in an op-ed for Forbes.

Advertisement

Three takeaways:

1. CMS rolled out the Hospital Readmission Reduction Program in 2012 to address high readmission rates, which cost the U.S. more than $41 billion annually. The program bases 3 percent of a hospital’s total Medicare reimbursement on readmission rates. Last year, it saved Medicare more than $2 billion, according to the Medicare Payment Advisory Commission.

2. Ms. Binder cited several studies that identify “unintended consequences” of the readmission reduction program. For example, a 2018 study published in JAMA found the program’s implementation was linked to a small — but statistically significant — increase in 30-day mortality rates among heart failure and pneumonia patients.

“Commenters suggest these problems call into question the value of the entire program. But let’s not throw the baby out with the bathwater,” Ms. Binder wrote. “Other studies have found promising results without the disturbing uptick in mortality rates, so the jury is still out.”

3. Ms. Binder said the most promising sign of the readmission reduction program’s success is the innovation and leadership coming from hospitals nationwide. She pointed to Boston University Medical Center, which lowered readmissions 30 percent by having nurse advocates conduct follow-up appointments at discharged patients’ homes.

“There is a need for ongoing vigilance, flexibility and refinements of the readmissions reduction program. But we should never let the inevitable need for refinements send us backward to the nonsensical policies of the old days,” Ms. Binder concluded. “This is a policy that works, as long as we make it better together.”

More articles on clinical leadership and infection control: 
New York county to ban unvaccinated kids from schools, malls amid measles outbreak
80% of Americans say HIV is serious national issue: 4 poll findings
Nurses’ work environments affect patient outcomes, study finds

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.